8.0 months, P=0.006); however, the differences between two groups failed to reach significance in patients with stage I or stage II disease ( Figure 2D,E,F ).
← all excerpts
Preoperative systemic immune-inflammation index predicts survival and recurrence in patients with resected primary pulmonary sarcomatoid carcinoma.
1
—
—